Press release shared on behalf of the National Allergy Strategy Group, of which Anaphylaxis UK is a member The National Allergy Strategy Group (NASG) welcomes last night’s House of Commons debate, in which the Parliamentary Under-Secretary of State for Education,

Allergies can impact almost every aspect of daily life — from school and travel to attending a hospital appointment. That is why Anaphylaxis UK advocates for a safer, allergy-aware approach across all environments. In healthcare settings, it may be assumed

A new Government consultation into allergy safety in schools launched today (5th March) following the announcement of Benedict’s Law coming into effect from September.  The consultation on Supporting Pupils with Medical Conditions and Allergies at school aims to deliver the core elements of the Benedict’s Law campaign, including spare adrenaline devices in schools, improved allergy training

Food Standards Scotland has launched a public consultation on how allergen and ingredient information is provided for non-prepacked foods — including meals from restaurants, cafés, takeaways and bakeries. This consultation is open until 17 May 2026.  Clear, accurate allergen information is essential for people

Anaphylaxis UK (formerly The Anaphylaxis Campaign) acknowledges the findings of the Fundraising Regulator’s report and welcomes the opportunity to further strengthen communication and compliance across our fundraising activity. While the report identifies areas for improvement, it is important to note

Valentine’s Day is a wonderful opportunity to show your partner how much you care — and if they live with serious food allergies, it’s also a chance to show that love through thoughtful preparation and understanding. With the right planning,

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice looked at popular allergy-related posts on TikTok, Instagram, Facebook and X to see what kind of misinformation is being shared and how people respond to it.  The researchers found that misleading content was very

You may have seen recent reports that Palforzia®, a licensed peanut oral immunotherapy treatment, has been discontinued. We can confirm that this is correct and outline below what this means for people living with peanut allergy.  The manufacturer of Palforzia®, Stallergenes Greer, has confirmed that

As we say goodbye to an expansive and innovative year, we are proud to reflect on the incredible achievements of our AllergyWise® training programme and the many inspiring organisations and professionals we have worked with along the way.  2025 was